查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1970795

微生物组化妆品市场－全球产业规模、份额、趋势、机会与预测：按产品、销售管道、地区和竞争对手划分，2021-2031年

Microbiome Cosmetic Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Sales Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球微生物组化妆品市场预计将从 2025 年的 4.4577 亿美元成长到 2031 年的 8.3468 亿美元，复合年增长率为 11.02%。

这些产品，包括含有有益生元、益生菌或后生元的局部用製剂，旨在平衡皮肤的共生微生物群，并强化角质层屏障。推动成长的关键因素包括消费者对皮肤健康的认识不断提高，以及他们越来越偏好能够修復皮肤屏障功能而不是仅仅提供美容功效的皮肤科成分。这种对功能性解决方案的需求在整个产业中也普遍存在。欧洲化妆品协会预测，到2024年，欧洲护肤市场的零售额将达到301亿欧元，该市场仍是业界规模最大、最活跃的类别。

市场概览
预测期 2027-2031
市场规模：2025年 4.4577亿美元
市场规模：2031年 8.3468亿美元
复合年增长率：2026-2031年 11.02%
成长最快的细分市场 在线的
最大的市场 北美洲

阻碍市场扩张的一大障碍是保鲜系统的技术复杂性，这些系统既要维持产品的保存期限，也要确保产品有效所需的有益菌丛不会被破坏。製造商面临的挑战在于，既要满足严格的安全标准以防止污染，也要维持活性微生物菌株的存活率。这通常需要复杂的供应链和高成本的包装创新来确保产品稳定性，从而阻碍了产品的广泛应用。

市场驱动因素

全球市场的主要驱动力之一是消费者对实证护肤的明显偏好，他们更重视产品的生物功效而非表面效果。这一趋势与人们对皮肤微生物组的深入了解密切相关，推动了对利用益生元和后生元修復角质层屏障的皮肤科产品的需求。主要企业已透过重组产品线来应对这种美容的「医学化」趋势，并实现了显着的营收成长。根据欧莱雅于2024年7月发布的《2024财年上半年财务业绩报告》，该公司旗下拥有领先微生物组品牌的「皮肤科美容事业部」的销售额较上年同期实现了16.4%的显着增长。

同时，敏感肌肉、酒糟和湿疹等皮肤问题的日益增多，加速了微生物群调节解决方案的普及。现代生活方式和环境压力正日益损害皮肤屏障功能，导致人们对能够主动恢復细菌生态系统平衡（而不仅仅是保湿）的治疗方法的需求不断增长。这种对功能性产品的需求在治疗性护肤相对于一般化妆品的成长中得到了清楚的体现。拜尔斯道夫（Byersdorf）在其2024年8月发布的「2024年上半年报告」中指出，其皮肤护理部门实现了8.3%的有机销售成长。此外，联合利华美容与健康部门报告称，2024年上半年销售额达65亿欧元，进一步证明了以健康为导向的护肤行业的庞大规模。

市场挑战

开发有效的保藏系统已成为市场发展的主要障碍，并造成了技术瓶颈。製造商面临两难：既要确保活菌菌株的活性，又要遵守严格的安全法规，避免污染。这种复杂性导致研发週期漫长，稳定性测试复杂，增加了生产成本，延缓了产品上市。此外，确保微生物活性通常需要低温运输物流和专门且昂贵的包装，这使得价格敏感型消费者难以购买此类产品，也增加了透过大型零售通路分销的难度。

这些挑战直接阻碍了产业的扩充性，迫使企业将注意力从快速产品部署转移到解决核心稳定性问题。处理这些敏感配方需要严格的科学监管和大量的人力资本投入。据个人护理产品协会（个人保健产品 Council）称，到2024年，该行业将僱用超过5700名STEM（科学、技术、工程和数学）领域的专业人员，以促进创新并维持严格的产品安全合规性。这种对先进技术专长的强烈依赖表明，产品防腐的门槛仍然很高，限制了能够成功从实验室走向全球市场的产品数量。

市场趋势

由DNA定序和人工智慧驱动的超个人化正在改变消费者互动方式，推动消费者从使用通用产品转向生物客製化照护。各大品牌正利用基因组分析和机器学习技术绘製个人皮肤微生物组图谱，提供针对特定细菌失衡的个人化建议。这种由科技主导的精细化服务减少了试验，提高了消费者忠诚度，并促进了数位化优先平台的普及。以数据为中心的美容公司已经充分证明了这种方法的经济效益。例如，Oddity Tech在2025年8月发布的2025年第二季财报中公布，其收入净额为2.41亿美元，年增25%，这主要得益于其人工智慧驱动的产品组合。

此外，市场正在拓展，涵盖头皮和身体的微生物群护理，从脸部保养多元化发展到全身「肌肤化」。消费者越来越倾向于寻求功能性护理产品，以与脸部肌肤相同的方式呵护头皮和身体肌肤，保护酸性保护膜免受紫外线等环境压力的侵害。这种广泛的关注点使製造商能够将以往商品化的屏障保护技术领域提升至高端水平，并获得更大的市场份额。花王株式会社于2025年2月发布的「截至2024年12月的财年合併会计」印证了这一领域的强劲增长，该业绩显示，公司「肌肤保护业务」的销售额增长了约30%，凸显了功能性身体保养的巨大潜力。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球微生物组化妆品市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品类型（精华液、乳霜、面膜、其他）
    • 销售管道（大型超级市场/超级市场、线上、药局、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美微生物组化妆品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲微生物组化妆品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区微生物化妆品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲微生物组化妆品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲微生物组化妆品市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球微生物组化妆品市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Eminence Organic Skin Care
  • L'Oreal SA
  • Outin Futures Inc.
  • Aurelia London Ltd
  • Johnson & Johnson Consumer Inc.
  • Revlon Consumer Products LLC
  • The Estee Lauder Companies Inc.
  • Watlea Enterprises, LLC
  • Murad, LLC
  • TULA Life, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 20935

The Global Microbiome Cosmetic Products Market is projected to expand from USD 445.77 Million in 2025 to USD 834.68 Million by 2031, reflecting a CAGR of 11.02%. These products, which include topical formulations infused with prebiotics, probiotics, or postbiotics, aim to balance the skin's commensal microbiota and strengthen the stratum corneum barrier. Growth is largely driven by increased consumer understanding of skin health biology and a preference for dermatological ingredients that offer barrier restoration rather than just aesthetic enhancements. This demand for functional solutions is mirrored in the wider industry; according to Cosmetics Europe, the European skincare segment generated €30.1 billion in retail sales in 2024, remaining the sector's largest and most active category.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 445.77 Million
Market Size 2031USD 834.68 Million
CAGR 2026-203111.02%
Fastest Growing SegmentOnline
Largest MarketNorth America

One significant hurdle impeding broader market expansion is the technical complexity of creating preservative systems that maintain shelf-life without destroying the beneficial bacteria required for product efficacy. Manufacturers encounter difficulties in balancing rigorous safety standards to prevent contamination with the necessity of maintaining the viability of active microbial strains. This often leads to complicated supply chains and a need for costly packaging innovations to ensure product stability, posing challenges for widespread adoption.

Market Driver

A primary driver of the global market is the definitive transition toward clinical and science-backed skincare, with consumers prioritizing biological effectiveness over superficial appearance. This movement is inextricably linked to growing knowledge of the skin microbiome, fueling the demand for dermatological products that utilize prebiotics and postbiotics to repair the stratum corneum barrier. Leading industry companies have restructured their offerings to align with this medicalization of beauty, yielding substantial revenue increases; according to L'Oreal's '2024 Half-Year Results' in July 2024, their Dermatological Beauty division, which houses key microbiome brands, reported an impressive like-for-like sales increase of 16.4%.

Concurrently, the increasing incidence of dermatological conditions such as sensitivity, rosacea, and eczema is quickening the uptake of microbiome-regulating solutions. Modern lifestyles and environmental stressors have led to more compromised skin barriers, creating a need for treatments that actively rebalance the bacterial ecosystem rather than simply providing hydration. This functional demand is visible in the growth of therapeutic skincare compared to general beauty; Beiersdorf's 'Half-Year Report 2024' in August 2024 noted that its Derma unit achieved 8.3% organic sales growth. Additionally, Unilever's Beauty & Wellbeing group reported a turnover of €6.5 billion for the first half of 2024, further illustrating the vast scale of the wellness-focused skincare sector.

Market Challenge

The formulation of effective preservative systems presents a major obstacle to market progress, creating a technical bottleneck. Manufacturers are caught in a paradox where they must adhere to strict safety regulations to avoid contamination while ensuring that live bacterial strains remain viable. This complexity demands prolonged research and development cycles and intricate stability testing, which drives up production costs and delays market entry. Moreover, ensuring active microbial survival often requires cold-chain logistics or specialized, expensive packaging, making these products less accessible to price-conscious consumers and complicating distribution in mass retail channels.

These challenges directly hinder the industry's scalability, diverting focus from rapid product rollout to resolving core stability problems. The need for rigorous scientific oversight to handle these sensitive formulations necessitates significant investment in human capital. According to the Personal Care Products Council, the industry employed more than 5,700 STEM professionals in 2024 to foster innovation and maintain strict product safety compliance. This heavy dependence on advanced technical expertise suggests that the hurdles regarding preservation remain high, limiting the number of products that can successfully move from the laboratory to the global market.

Market Trends

Hyper-personalization through DNA sequencing and AI is transforming consumer engagement by replacing generic products with biologically customized regimens. Brands are increasingly utilizing genomic analysis and machine learning to map individual skin microbiomes, providing tailored recommendations that target specific bacterial imbalances. This technology-driven precision reduces trial-and-error, encouraging high consumer loyalty and the adoption of digital-first platforms. The financial success of this approach is reflected in data-centric beauty firms; for instance, Oddity Tech reported net revenue of $241 million in its 'Second Quarter 2025 Financial Results' in August 2025, marking a 25% year-over-year increase fueled by its AI-powered portfolio.

Additionally, the market is expanding into scalp and body microbiome care, diversifying beyond facial applications toward the "skinification" of the whole body. Consumers increasingly treat the scalp and body with the same care as facial skin, seeking functional treatments that protect the acid mantle against environmental aggressors like UV radiation. This broader focus enables manufacturers to capture a larger market share by premiumizing traditionally commoditized sectors with barrier-protecting innovations. The strong growth of this segment is evidenced by Kao Corporation's 'Consolidated Financial Results for the Year Ended December 31, 2024' released in February 2025, which showed that sales in its Skin Protection business rose by approximately 30%, highlighting the significant opportunity in functional body care.

Key Market Players

  • Eminence Organic Skin Care
  • L'Oreal S.A.
  • Outin Futures Inc.
  • Aurelia London Ltd
  • Johnson & Johnson Consumer Inc.
  • Revlon Consumer Products LLC
  • The Estee Lauder Companies Inc.
  • Watlea Enterprises, LLC
  • Murad, LLC
  • TULA Life, Inc.

Report Scope

In this report, the Global Microbiome Cosmetic Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microbiome Cosmetic Products Market, By Product

  • Serum
  • Creams
  • Masks
  • Others

Microbiome Cosmetic Products Market, By Sales Channel

  • Hypermarkets/Supermarkets
  • Online
  • Drug Stores
  • Others

Microbiome Cosmetic Products Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microbiome Cosmetic Products Market.

Available Customizations:

Global Microbiome Cosmetic Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microbiome Cosmetic Products Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Serum, Creams, Masks, Others)
    • 5.2.2. By Sales Channel (Hypermarkets/Supermarkets, Online, Drug Stores, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Microbiome Cosmetic Products Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Sales Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Microbiome Cosmetic Products Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Sales Channel
    • 6.3.2. Canada Microbiome Cosmetic Products Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Sales Channel
    • 6.3.3. Mexico Microbiome Cosmetic Products Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Sales Channel

7. Europe Microbiome Cosmetic Products Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Sales Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Microbiome Cosmetic Products Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Sales Channel
    • 7.3.2. France Microbiome Cosmetic Products Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Sales Channel
    • 7.3.3. United Kingdom Microbiome Cosmetic Products Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Sales Channel
    • 7.3.4. Italy Microbiome Cosmetic Products Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Sales Channel
    • 7.3.5. Spain Microbiome Cosmetic Products Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Sales Channel

8. Asia Pacific Microbiome Cosmetic Products Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Sales Channel
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Microbiome Cosmetic Products Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Sales Channel
    • 8.3.2. India Microbiome Cosmetic Products Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Sales Channel
    • 8.3.3. Japan Microbiome Cosmetic Products Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Sales Channel
    • 8.3.4. South Korea Microbiome Cosmetic Products Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Sales Channel
    • 8.3.5. Australia Microbiome Cosmetic Products Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Sales Channel

9. Middle East & Africa Microbiome Cosmetic Products Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Sales Channel
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Microbiome Cosmetic Products Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Sales Channel
    • 9.3.2. UAE Microbiome Cosmetic Products Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Sales Channel
    • 9.3.3. South Africa Microbiome Cosmetic Products Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Sales Channel

10. South America Microbiome Cosmetic Products Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Sales Channel
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Microbiome Cosmetic Products Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Sales Channel
    • 10.3.2. Colombia Microbiome Cosmetic Products Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Sales Channel
    • 10.3.3. Argentina Microbiome Cosmetic Products Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Sales Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Microbiome Cosmetic Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Eminence Organic Skin Care
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. L'Oreal S.A.
  • 15.3. Outin Futures Inc.
  • 15.4. Aurelia London Ltd
  • 15.5. Johnson & Johnson Consumer Inc.
  • 15.6. Revlon Consumer Products LLC
  • 15.7. The Estee Lauder Companies Inc.
  • 15.8. Watlea Enterprises, LLC
  • 15.9. Murad, LLC
  • 15.10. TULA Life, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer